In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
The goal of our new XBridge program is to open a new door for researchers facing the sudden loss of support.
Manager.bg
Visit: BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
BioMed X has started a program to match researchers who have previously received funding from the U.S. National Institutes of Health (NIH) who have lost funding with supporters from the pharmaceutical industry.
Thansettakij
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Sina Finance
Visit: BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
BioMed X has launched a program to match U.S. National Institutes of Health fellows who have lost funding sponsors from the pharmaeceutical industry.
Bloomberg Línea
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
HKEJ
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
CNYES
Visit: BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
BioMed X has launched a program to connect National Institutes of Health (NIH) grantees who have lost funding with pharmaceutical industry funders.
Lianhe Zaobao
Visit: BioMed X partners with the Barbadian Government to optimise cardiometabolic treatment options
BioMed X partners with the Barbadian Government to optimise cardiometabolic treatment options
Manufacturing Chemist
Visit: Promotion of local pharmaceutical production
Promotion of local pharmaceutical production
Kurzy
Visit: CARICOM meeting calls for unity in the face of global challenges
CARICOM meeting calls for unity in the face of global challenges
Prensa Latina
Visit: BioMed X Launches Call to Support U.S. Scientists Facing NIH Funding Loss
BioMed X Launches Call to Support U.S. Scientists Facing NIH Funding Loss
ChemistryViews
Visit: BioMed X Launches XBridge Program to Support Biomedical Researchers Impacted by NIH Funding Gaps
BioMed X Launches XBridge Program to Support Biomedical Researchers Impacted by NIH Funding Gaps
FirstWord PHARMA
Visit: Biotech news from around the world
Biotech news from around the world
Nature Biotechnology
Visit: AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
PharmiWeb.com
Visit: AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
Medical Device News Magazine
Visit: AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
AION Labs, In Continued Partnership with BioMed X, Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations
PR Newswire
Visit: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
等信源发布
Visit: Ursula von der Leyen’s Historic Visit to Barbados: A New Era of Partnership and Progress!
Ursula von der Leyen’s Historic Visit to Barbados: A New Era of Partnership and Progress!
EU Debates
Visit: Ursula von der Leyen’s Historic Visit to Barbados: Strengthening Ties with CARICOM & BioMed X Deals!
Ursula von der Leyen’s Historic Visit to Barbados: Strengthening Ties with CARICOM & BioMed X Deals!
EU Debates
Visit: BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados
BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados
Biotech Newswire
Visit: German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals
German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals
Fierce Biotech